[
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Maintains Analyst Ratings Amid Target Adjustments",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to invest in. On February 6, RBC Capital lowered its price target on Boston Scientific Corporation (NYSE:BSX) to $115 from $130 and maintained an Outperform rating on the shares. RBC made the move in response to Boston Scientific’s Q4 2025 earnings share on […]",
    "url": "https://finnhub.io/api/news?id=52cdb8536e12666828ec992ab8073f335e121d9e411d01957a4d9a5268096b42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771156373,
      "headline": "Boston Scientific Corporation (BSX) Maintains Analyst Ratings Amid Target Adjustments",
      "id": 139105965,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to invest in. On February 6, RBC Capital lowered its price target on Boston Scientific Corporation (NYSE:BSX) to $115 from $130 and maintained an Outperform rating on the shares. RBC made the move in response to Boston Scientific’s Q4 2025 earnings share on […]",
      "url": "https://finnhub.io/api/news?id=52cdb8536e12666828ec992ab8073f335e121d9e411d01957a4d9a5268096b42"
    }
  }
]